Clin2
NCT07674446Likely a fitRecruiting

Diosmin tablet study in healthy adults

Healthy Volunteers

This trial tests a 1000 mg Diosmin tablet (a flavonoid used for vein health) taken with food to see how it's processed in healthy volunteers. You can join if you are generally healthy, non-smoker, and not taking other medications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
72 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old
  • Your body mass index (BMI) is between 18.5 and 30
  • You are a non-smoker or quit smoking at least 6 months ago
  • You do not drink alcohol regularly
  • You are not taking any prescription, over-the-counter, or herbal medicines
  • If female, you use a medically accepted birth control method or are past childbearing age

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07811063Not yet recruiting· Phase 1
Testing a new tablet in healthy adults

This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.

Auckland
NCT07161180Recruiting· Phase 1
Study of PBK_M2301 in Healthy Adults

This trial tests how a new medicine, PBK_M2301, moves through the body in healthy adults. It aims to find out how the drug is absorbed and eliminated to guide future studies.

Seoul, Seoul
NCT07594847Recruiting· Phase 1
Safety study of HDM1002 tablets on heart rhythm in healthy adults

This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.

Zibo, Shangdong
NCT07760246Recruiting· Phase 1
Heart safety study of verducatib in healthy adults

This study tests how different doses of the drug verducatib affect the heart in healthy adults. Participation helps ensure the drug is safe before it's studied in patients.

Mannheim
NCT06867406Not yet recruiting· Phase 1
Safety study of a new tablet in healthy adults

This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.

Beijing, Beijing Municipality
NCT06584799Recruiting· Phase 3
Medication for pelvic vein disorder symptoms

This trial tests a venoactive drug (a medication that improves vein tone and blood flow) to see if it relieves symptoms like pelvic pain, pain during sex, and discomfort in the lower belly caused by pelvic varicose veins (enlarged veins). It may help people who have these symptoms confirmed by ultrasound.

Moskva

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.